The sequencing phase of the human genome project is now near completion, but then what? An even harder challenge remains — to identify the structures and functions of all proteins encoded in the ...

A successful partnership between Pitt’s BioForge subsidiary and a New York-based biotech startup has kept the latter in Pittsburgh. In an interview with the Business Times, their CEOs explained why.

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...

Terrestrial Bio has dosed the first patients in a Phase I clinical trial evaluating its patch that delivers GLP-1 therapeutic ...

UCSF researchers are using tiny "mini-organs" to model disease, personalize treatment, and understand human development. They ...

GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...

From this basis emerged the clinical confidence that diagnostic truth lived somewhere at the far end of a resolution curve. Butterfly Network may be challenging that premise from the ground up.

Unity, a microreactor from Houston-based Deployable Energy, is the latest of the three to reach criticality as part of a ...